Atlas Trials

Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection

Clinical trial NCT03399903 · COMPLETED

Trial details

NCT number
NCT03399903
Sponsor
AIDS Healthcare Foundation
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
HIV-1-infectionGut Inflammation
Start date
2017-05-01
Primary completion
2019-03-22
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.